The effects of dexamethasone and IL-1β on histone H3 methylation in A549 cells

H. Wada, M. Kagoshima, P. J. Barnes, I. M. Adcock (London, United Kingdom)

Source: Annual Congress 2003 - Molecular biology of chronic lung disease and lung cancer
Session: Molecular biology of chronic lung disease and lung cancer
Session type: Poster Discussion
Number: 1503
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Tightly compacted within the nucleus, DNA is inaccessible to transcription factors and RNA polymerase II. The histone code proposes that gene transcription occurs as a result of post-translational changes in histones. Methylation of histone H3 residues Lys(K)4 and K9, particularly their di- or tri-methylated status, have been reported to be involved in the activation and the suppression of the transcription. In addition, we have previously reported that 5-aza cytidine (5-aza), a methylase inhibitor, enhanced IL-1β stimulated GM-CSF release and synergised with TSA, a deacetylase inhibitor, to block dexamethasone-induced suppression. We thus hypothesised that histone H3 K4/K9 methylation was involved in the regulation of inflammatory genes. A549 cells were incubated with dexamethasone (Dex, 10-12-10-6M) and/or IL-1β (1 ng/ml) for 0, 1, 4, 24hr and histone H3 K4/K9 tri-/dimethylation was measured by Western blotting. Both Dex and IL-1β induced a reduction in K9 di-methylation at 4hr followed by a significant induction at 24hr. Dex was able to attenuate the effect of IL-1β on K9 dimethylation at 4hr. Histone H3K4 dimethylation did not change demonstrably over 24 hr. Chromatin immunoprecipitation assays showed that K9 methylation at the NF-kB site in the GM-CSF promoter was enhanced by both IL-1β and Dex within 1hr. In combination with Real Time PCR, it also showed K9 methylation at the NF-kB site in the SLPI promoter was enhanced by IL-1β and Dex either alone or in combination at 24hr. This data suggests that histone H3 methylation may play a role in inflammatory gene expression induced by IL-1β.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Wada, M. Kagoshima, P. J. Barnes, I. M. Adcock (London, United Kingdom). The effects of dexamethasone and IL-1β on histone H3 methylation in A549 cells. Eur Respir J 2003; 22: Suppl. 45, 1503

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cytokine-induced EGFR protein release in BEAS-2B cells; relation with histone acetylation and methylation status
Source: Eur Respir J 2005; 26: Suppl. 49, 556s
Year: 2005

Effect of cigarette smoke extract (CSE) on histone acetylation of lung fibroblasts in vitro compared to histone acetylation in patients with lung emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 583s
Year: 2006

Histone acetylation and deacetylation: importance in inflammatory lung diseases
Source: Eur Respir J 2005; 25: 552-563
Year: 2005



Global histone H3 lysine 4 (H3K4) dimethylation is an important prognostic factor in lung cancer
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012


Single and combined effects of cisplatin, sodium butyrate and sirtinol on covalent histone modifications in human cell lines
Source: Eur Respir J 2007; 30: Suppl. 51, 146s
Year: 2007

Dexamethasone inhibits phosphorylation at histone H3 (Ser 10)
Source: Eur Respir J 2004; 24: Suppl. 48, 98s
Year: 2004

IL-1β induced histone H3-K4 tri-methylation and RNA polymerase II recruitment to the SLPI gene
Source: Eur Respir J 2005; 26: Suppl. 49, 556s
Year: 2005

The effect of histone methyaltion on GM-CSF and SLPI expression
Source: Eur Respir J 2004; 24: Suppl. 48, 437s
Year: 2004

Decreased histone deacetylase activity in COPD
Source: Annual Congress 2008 - Epigenetic modifications in lung disease
Year: 2008


Histone deacetylase activity and gene expression in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001

DNA methylation and histone modifications of susceptibility in COPD and lung cancer
Source: Annual Congress 2011 - Why is epigenetics important for lung disease?
Year: 2011


Citrullinated histone H3 is increased in blood of asthma subjects
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019

Histone deacetylase activity is reduced in COPD. Modulation by theophylline
Source: Eur Respir J 2003; 22: Suppl. 45, 4s
Year: 2003

Cigarette smoke increases histone acetylation in alveolar epithelial cells: a mechanism for enhanced gene expression
Source: Eur Respir J 2002; 20: Suppl. 38, 377s
Year: 2002

Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells
Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer
Year: 2019

Regulation of eosinophil and neutrophil apoptosis by histone hyperacetylation
Source: Eur Respir J 2003; 22: Suppl. 45, 572s
Year: 2003

Reversal of DNA and histone methylation
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006


I?B? glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES
Source: Eur Respir J 2011; 38: 1444-1452
Year: 2011



Steroids and histone deacetylase in ventilation-induced gene transcription
Source: Eur Respir J 2007; 30: 865-877
Year: 2007